Nov 20, 2017
LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million
Nov 07, 2017
LivaNova to Present at the Piper Jaffray and Berenberg Conferences
Nov 02, 2017
LivaNova Reports Third Quarter 2017 Results
Nov 01, 2017
LivaNova Recognizes Epilepsy Awareness Month This November
Oct 09, 2017
LivaNova Receives FDA Approvals for SenTiva Device and Next-Generation VNS Therapy Programming System for Treatment of Epilepsy